Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Low-grade Gliomas”

228 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 228 results

Testing effectiveness (Phase 2)Study completedNCT00615927
What this trial is testing

Phase II Imatinib + Hydroxyurea in Treatment of Patients With Recurrent/Progressive Grade II Low-Grade Glioma (LGG)

Who this might be right for
GlioblastomaGliosarcoma
Duke University 64
Large-scale testing (Phase 3)Study completedNCT00003375
What this trial is testing

Observation or Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Low-Grade Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Radiation Therapy Oncology Group 370
Large-scale testing (Phase 3)Looking for participantsNCT05566795
What this trial is testing

DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2)

Who this might be right for
Low-grade GliomaRapidly Accelerated Fibrosarcoma (RAF) Altered GliomaPediatric Low-grade Glioma
Day One Biopharmaceuticals, Inc. 400
Early research (Phase 1)Looking for participantsNCT05609994
What this trial is testing

ViCToRy: Vorasidenib in Combination With Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade Gliomas

Who this might be right for
Low Grade Glioma of Brain
Katy Peters, MD, PhD 48
Not applicableNot Yet RecruitingNCT04745156
What this trial is testing

A Study Using Brain Stimulation and Behavioral Therapy to Increase Extent of Resection in Low-Grade Gliomas

Who this might be right for
GliomaGlioma IntracranialGliomas Benign+3 more
Medical College of Wisconsin 3
Testing effectiveness (Phase 2)Study completedNCT03557359
What this trial is testing

Nivolumab for Recurrent or Progressive IDH Mutant Gliomas

Who this might be right for
Gliomas
Fabio Iwamoto, MD 35
Not applicableNot Yet RecruitingNCT07469735
What this trial is testing

Vorasidenib Guided by AGX PET in Recurrent/Low-grade Glioma

Who this might be right for
GliomaDiffuse GliomaRecurrent Gliomas
Huashan Hospital 10
Not applicableUnknownNCT05019196
What this trial is testing

FMRI Study of Functional Reorganization in Glioma Patients

Who this might be right for
Glioma
First Affiliated Hospital Xi'an Jiaotong University 100
Not applicableApproved For MarketingNCT05760586
What this trial is testing

Expanded Access Program (EAP) for Tovorafenib (DAY101) in RAF-Altered, Relapsed or Refractory Low-Grade Glioma

Who this might be right for
Low-grade Glioma
Day One Biopharmaceuticals, Inc.
Testing effectiveness (Phase 2)Study completedNCT03233204
What this trial is testing

Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmAnn Arbor Stage III Childhood Non-Hodgkin LymphomaAnn Arbor Stage IV Childhood Non-Hodgkin Lymphoma+33 more
National Cancer Institute (NCI) 6
Not applicableStudy completedNCT04365647
What this trial is testing

Intra-operative Variation in Size of Brain Tumors After Craniotomy

Who this might be right for
Brain Tumor, Primary
Sheri Kashmir Institute of Medical Sciences 51
Not applicableEnrolling By InvitationNCT04063514
What this trial is testing

The Use of Focused Ultrasound and DCE K-trans Imaging to Evaluate Permeability of the Blood-Brain Barrier

Who this might be right for
Low Grade Glioma of Brain
Neurological Associates of West Los Angeles 15
Not applicableUnknownNCT03154801
What this trial is testing

Early Detection and Paramedical Care of Sexual Difficulties in Nervous System Diseases: Example of Multiple Sclerosis and Brain Tumors (NEUROSEX)

Who this might be right for
Low Grade Glioma of BrainMultiple SclerosisSexual Dysfunctions
Assistance Publique - Hôpitaux de Paris 54
Testing effectiveness (Phase 2)Ended earlyNCT04544007
What this trial is testing

A Phase II Trial of Poly-ICLC for Low-Grade Gliomas

Who this might be right for
NF1Low-grade Glioma
University of Alabama at Birmingham 3
Early research (Phase 1)Active Not RecruitingNCT03749187
What this trial is testing

BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas

Who this might be right for
GlioblastomaIDH1 Gene MutationIDH2 Gene Mutation+7 more
University of California, San Francisco 78
Testing effectiveness (Phase 2)Study completedNCT01497860
What this trial is testing

Vinorelbine for Children With Progressive or Recurrent Low-grade Gliomas

Who this might be right for
Low-grade Glioma
Eugene Hwang 13
Large-scale testing (Phase 3)Not Yet RecruitingNCT07004075
What this trial is testing

FCN-159 Monotherapy Versus Chemotherapy by Investigator's Choice in Pediatric Low-grade Glioma Patients With BRAF Alteration

Who this might be right for
Low-grade GliomaPediatric Low-grade GliomaspLGG With BRAF Alteration
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 102
Testing effectiveness (Phase 2)Looking for participantsNCT07110246
What this trial is testing

Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas

Who this might be right for
BRAF V600 MutationLow-grade GliomaLow Grade Glioma of Brain+1 more
University of California, San Francisco 96
Testing effectiveness (Phase 2)Study completedNCT01295944
What this trial is testing

Carboplatin and Bevacizumab for Recurrent Ependymoma

Who this might be right for
EpendymomaAnaplastic Ependymoma
National Cancer Institute (NCI) 35
Very early researchStudy completedNCT00795457
What this trial is testing

Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With High-Risk WHO Grade II Astrocytomas and Oligo-Astrocytomas

Who this might be right for
AstrocytomaOligo-AstrocytomaGlioma
Ian F. Pollack, M.D. 13
Load More Results